. Author manuscript; available in PMC: 2018 Feb 28.

Published in final edited form as: ACS Nano. 2017 Feb 8;11(2):1869–1883. doi: 10.1021/acsnano.6b07895

Table 3.

Molar dose and mass dose conversion of III-V materials used in vitro and in vivo.

Materials	Molar weight (g/mol)	In vitro^a		In vivo^b
Materials	Molar weight (g/mol)	Molar dose (µmol/mL)	Mass dose (µg/mL)	Molar dose (mmol/kg)	Mass dose (mg/kg)
m-GaAs	144.65	0.043∼0.7	6.25∼100	0.014	2
n-GaAs	144.65	0.043∼0.7	6.25∼100	0.014	2
m-InAs	189.74	0.043∼0.7	8.15∼132.82	0.014	2.62
n-InAs	189.74	0.043∼0.7	8.15∼132.82	0.014	2.62
GaCl₃	176.07	0.043∼0.7	7.57∼123.25	0.014	2.43
InCl₃	221.18	0.043∼0.7	9.51∼154.82	0.014	3.06
NaAsO₂ (AsIII)	129.91	0.043∼0.7	5.59∼90.94	0.014	1.80
NaH₂AsO₄·7H₂O (AsV)	290.03	0.043∼0.7	12.47∼203.02	0.014	4.01
ZnO (positive control)	81.38	0.043∼0.7	3.50∼56.97	0.014	1.14
MUS (positive control)	60.08	0.7	42.06	0.083	5

In vitro study was performed in THP-1 and BEAS-2B cells.

In vivo study was performed in mice at 40 h and 21 D exposure